Výsledky vyhledávání - "Hildi J Hagedorn"

Akademický článek

Healthcare quality measures in implementation research: advantages, risks and lessons learned

Autor: Allison M. Gustavson, Hildi J. Hagedorn, Leah E. Jesser, Marie E. Kenny, Barbara A. Clothier, Mark Bounthavong, Princess E. Ackland, Adam J. Gordon, Alex H. S. Harris

Publikováno v: Health Research Policy and Systems, Vol 20, Iss 1, Pp 1-6 (2022)

Abstract Implementation studies evaluate strategies to move evidence-based practices into routine clinical practice. Often, implementation scientists use healthcare quality measures to evaluate the integration of an evidence-based clinical practice i

Externí odkaz: https://doaj.org/article/f9fde5f5968b4eaab254d74ef2dde9b0

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Frequency and costs of low-value preoperative tests for patients undergoing low-risk procedures in the veterans health administration

Autor: Alex H. S. Harris, Thomas Bowe, Robin N. Kamal, Erika D. Sears, Mary Hawn, Dan Eisenberg, Andrea K. Finlay, Hildi J. Hagedorn, Seshadri Mudumbai

Publikováno v: Perioperative Medicine, Vol 11, Iss 1, Pp 1-8 (2022)

Abstract Background Clinical practice guidelines discourage routine preoperative screening tests for patients undergoing low-risk procedures. This study sought to determine the frequency and costs of potentially low-value preoperative screening tests

Externí odkaz: https://doaj.org/article/cde8c29c205a45068796c58b5b4db226

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention (EMPOWER-ED): Randomized controlled trial protocol

Autor: Michael A. Cucciare, Hildi J. Hagedorn, Mark Bounthavong, Traci H. Abraham, Carolyn J. Greene, Xiaotong Han, Lakiesha Kemp, Kathy Marchant, Penny White, Keith Humphreys

Publikováno v: Contemporary Clinical Trials Communications, Vol 29, Iss , Pp 100994- (2022)

Background: Long-term benzodiazepine dependence carries significant health risks which might be reduced with low-cost patient self-management interventions. A booklet version of one such intervention (Eliminating Medications Through Patient Ownership

Externí odkaz: https://doaj.org/article/5f134121968648a5bff066dfa8091a19

Zobrazit plný text záznamu

Akademický článek

Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities

Autor: Eric J. Hawkins, Anissa N. Danner, Carol A. Malte, Brittany E. Blanchard, Emily C. Williams, Hildi J. Hagedorn, Adam J. Gordon, Karen Drexler, Jennifer L. Burden, Jennifer Knoeppel, Aline Lott, George G. Sayre, Amanda M. Midboe, Andrew J. Saxon

Publikováno v: Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-12 (2021)

Abstract Background Improving access to medication treatment of opioid use disorder (MOUD) is a national priority, yet common modifiable barriers (e.g., limited provider knowledge, negative beliefs about MOUD) often challenge implementation of MOUD d

Externí odkaz: https://doaj.org/article/11d5a9a6824645aca683bd156b0591bc

Zobrazit plný text záznamu

Akademický článek

Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention

Autor: Allison M. Gustavson, Marie E. Kenny, Jennifer P. Wisdom, Hope A. Salameh, Princess E. Ackland, Adam J. Gordon, Hildi J. Hagedorn

Publikováno v: Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-7 (2021)

Abstract Background The Veterans Health Administration (VHA) is invested in expanding access to medication treatment for opioid use disorder (MOUD) to save lives. Access varies across VHA facilities and, thus, requires implementation strategies to pr

Externí odkaz: https://doaj.org/article/ceb594de3cd34a41a7cba885c6ec63c2

Zobrazit plný text záznamu

Akademický článek

Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration

Autor: Allison M. Gustavson, Jennifer P. Wisdom, Marie E. Kenny, Hope A. Salameh, Princess E. Ackland, Barbara Clothier, Siamak Noorbaloochi, Adam J. Gordon, Hildi J. Hagedorn

Publikováno v: Implementation Science Communications, Vol 2, Iss 1, Pp 1-13 (2021)

Abstract Background Despite the risk of negative sequelae from opioid use disorder (OUD) and clinical guidelines for the use of effective medication treatment for OUD (M-OUD), many Veterans Health Administration (VHA) providers and facilities lag in

Externí odkaz: https://doaj.org/article/61e55535b019491bbae7035d544466f4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání